Literature DB >> 9774665

Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid.

E R Hofmann1, M Boyanapalli, D J Lindner, X Weihua, B A Hassel, R Jagus, P L Gutierrez, D V Kalvakolanu, E R Hofman.   

Abstract

Interferons (IFNs) and retinoids are potent biological response modifiers. By using JAK-STAT pathways, IFNs regulate the expression of genes involved in antiviral, antitumor, and immunomodulatory actions. Retinoids exert their cell growth-regulatory effects via nuclear receptors, which also function as transcription factors. Although these ligands act through distinct mechanisms, several studies have shown that the combination of IFNs and retinoids synergistically inhibits cell growth. We have previously reported that IFN-beta-all-trans-retinoic acid (RA) combination is a more potent growth suppressor of human tumor xenografts in vivo than either agent alone. Furthermore, the IFN-RA combination causes cell death in several tumor cell lines in vitro. However, the molecular basis for these growth-suppressive actions is unknown. It has been suggested that certain gene products, which mediate the antiviral actions of IFNs, are also responsible for the antitumor actions of the IFN-RA combination. However, we did not find a correlation between their activities and cell death. Therefore, we have used an antisense knockout approach to directly identify the gene products that mediate cell death and have isolated several genes associated with retinoid-IFN-induced mortality (GRIM). In this investigation, we characterized one of the GRIM cDNAs, GRIM-12. Sequence analysis suggests that the GRIM-12 product is identical to human thioredoxin reductase (TR). TR is posttranscriptionally induced by the IFN-RA combination in human breast carcinoma cells. Overexpression of GRIM-12 causes a small amount of cell death and further enhances the susceptibility of cells to IFN-RA-induced death. Dominant negative inhibitors directed against TR inhibit its cell death-inducing functions. Interference with TR enzymatic activity led to growth promotion in the presence of the IFN-RA combination. Thus, these studies identify a novel function for TR in cell growth regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774665      PMCID: PMC109235          DOI: 10.1128/MCB.18.11.6493

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation.

Authors:  G M Cohen; X M Sun; R T Snowden; D Dinsdale; D N Skilleter
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

2.  DAP genes: novel apoptotic genes isolated by a functional approach to gene cloning.

Authors:  A Kimchi
Journal:  Biochim Biophys Acta       Date:  1998-04-17

Review 3.  c-Myc and apoptosis.

Authors:  G Packham; J L Cleveland
Journal:  Biochim Biophys Acta       Date:  1995-07-28

4.  Thioredoxin and thioredoxin reductase.

Authors:  A Holmgren; M Björnstedt
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Selenite and selenodiglutathione: reactions with thioredoxin systems.

Authors:  M Björnstedt; S Kumar; A Holmgren
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

Authors:  C L Willman; C E Sever; M G Pallavicini; H Harada; N Tanaka; M L Slovak; H Yamamoto; K Harada; T C Meeker; A F List
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

7.  Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation.

Authors:  R Kumar; I Atlas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

8.  Cloning and sequencing of a human thioredoxin reductase.

Authors:  P Y Gasdaska; J R Gasdaska; S Cochran; G Powis
Journal:  FEBS Lett       Date:  1995-10-02       Impact factor: 4.124

9.  Thioredoxin, a mediator of growth inhibition, maps to 9q31.

Authors:  A Heppell-Parton; A Cahn; A Bench; N Lowe; H Lehrach; G Zehetner; P Rabbitts
Journal:  Genomics       Date:  1995-03-20       Impact factor: 5.736

10.  Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.

Authors:  D J Lindner; E C Borden; D V Kalvakolanu
Journal:  Clin Cancer Res       Date:  1997-06       Impact factor: 12.531

View more
  27 in total

Review 1.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Imbalance in Protein Thiol Redox Regulation and Cancer-Preventive Efficacy of Selenium.

Authors:  Rayudu Gopalakrishna; Usha Gundimeda; Sarah Zhou; Kristen Zung; Kaitlyn Forell; Arne Holmgren
Journal:  React Oxyg Species (Apex)       Date:  2016-05-25

Review 3.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

4.  GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.

Authors:  Chengchen Lufei; Jing Ma; Guochang Huang; Tong Zhang; Veronica Novotny-Diermayr; Chin Thing Ong; Xinmin Cao
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

Review 5.  [Expression of selenoproteins in monocytes and macrophages--implications for the immune system].

Authors:  R Ebert-Dümig; J Seufert; D Schneider; J Köhrle; N Schütze; F Jakob
Journal:  Med Klin (Munich)       Date:  1999-10-15

6.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.

Authors:  Taegun Seo; Daeyoup Lee; Young Sam Shim; Jon E Angell; Natesa V Chidambaram; Dhananjaya V Kalvakolanu; Joonho Choe
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

8.  The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.

Authors:  Jun Zhang; Jinbo Yang; Sanjit K Roy; Silvia Tininini; Jiadi Hu; Jacqueline F Bromberg; Valeria Poli; George R Stark; Dhananjaya V Kalvakolanu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

Review 9.  GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.

Authors:  Shreeram C Nallar; Dhan V Kalvakolanu
Journal:  Cytokine Growth Factor Rev       Date:  2016-09-15       Impact factor: 7.638

10.  JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1.

Authors:  Kornelia Edes; Pamela Cassidy; Paul J Shami; Philip J Moos
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.